Literature DB >> 23361394

Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.

Tiffany L Sudduth1, David K Powell, Charles D Smith, Abigail Greenstein, Donna M Wilcock.   

Abstract

Vascular dementia (VaD) is the second leading cause of dementia behind Alzheimer's disease (AD) and is a frequent comorbidity with AD, estimated to occur in as many as 40% of AD patients. The causes of VaD are varied and include chronic cerebral hypoperfusion, microhemorrhages, hemorrhagic infarcts, or ischemic infarcts. We have developed a model of VaD by inducing hyperhomocysteinemia (HHcy) in wild-type mice. By placing wild-type mice on a diet deficient in folate, B6, and B12 and supplemented with excess methionine, we induced a moderate HHcy (plasma level homocysteine 82.93 ± 3.561 μmol). After 11 weeks on the diet, the hyperhomocysteinemic mice showed a spatial memory deficit as assessed by the 2-day radial-arm water maze. Also, magnetic resonance imaging and subsequent histology revealed significant microhemorrhage occurrence. We found neuroinflammation induced in the hyperhomocysteinemic mice as determined by elevated interleukin (IL)-1β, tumor necrosis factor (TNF)α, and IL-6 in brain tissue. Finally, we found increased expression and increased activity of the matrix metalloproteinase 2 (MMP2) and MMP9 systems that are heavily implicated in the pathogenesis of cerebral hemorrhage. Overall, we have developed a dietary model of VaD that will be valuable for studying the pathophysiology of VaD and also for studying the comorbidity of VaD with other dementias and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361394      PMCID: PMC3652696          DOI: 10.1038/jcbfm.2013.1

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats.

Authors:  Michael Pirchl; Celine Ullrich; Christian Humpel
Journal:  Eur J Neurosci       Date:  2010-11       Impact factor: 3.386

2.  The incidence of vascular dementia in Canada: a comparison with Europe and East Asia.

Authors:  M F Dubois; R Hébert
Journal:  Neuroepidemiology       Date:  2001-08       Impact factor: 3.282

3.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.

Authors:  Z Chen; A C Karaplis; S L Ackerman; I P Pogribny; S Melnyk; S Lussier-Cacan; M F Chen; A Pai; S W John; R S Smith; T Bottiglieri; P Bagley; J Selhub; M A Rudnicki; S J James; R Rozen
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

Review 4.  Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Authors:  J W Eikelboom; E Lonn; J Genest; G Hankey; S Yusuf
Journal:  Ann Intern Med       Date:  1999-09-07       Impact factor: 25.391

5.  Severe methylenetetrahydrofolate reductase deficiency in mice results in behavioral anomalies with morphological and biochemical changes in hippocampus.

Authors:  Nafisa M Jadavji; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Genet Metab       Date:  2012-04-04       Impact factor: 4.797

6.  Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.

Authors:  Noriyuki Akahoshi; Chiho Kobayashi; Yasuki Ishizaki; Takashi Izumi; Toshiyuki Himi; Makoto Suematsu; Isao Ishii
Journal:  Hum Mol Genet       Date:  2008-03-25       Impact factor: 6.150

7.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice.

Authors:  Aron M Troen; Melissa Shea-Budgell; Barbara Shukitt-Hale; Donald E Smith; Jacob Selhub; Irwin H Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

8.  Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.

Authors:  Donna M Wilcock; Dave Morgan; Marcia N Gordon; Tiffany L Taylor; Lisa A Ridnour; David A Wink; Carol A Colton
Journal:  J Neuroinflammation       Date:  2011-09-09       Impact factor: 8.322

9.  Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.

Authors:  Donna M Wilcock; Qun Zhao; Dave Morgan; Marcia N Gordon; Angela Everhart; Joan G Wilson; Jennifer E Lee; Carol A Colton
Journal:  ASN Neuro       Date:  2011-11-30       Impact factor: 4.146

10.  Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.

Authors:  Donna M Wilcock; Matthew R Lewis; William E Van Nostrand; Judianne Davis; Mary Lou Previti; Nastaran Gharkholonarehe; Michael P Vitek; Carol A Colton
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

View more
  71 in total

1.  Association of Neuroprotective Effect of Di-O-Demethylcurcumin on Aβ25-35-Induced Neurotoxicity with Suppression of NF-κB and Activation of Nrf2.

Authors:  Decha Pinkaew; Chatchawan Changtam; Chainarong Tocharus; Piyarat Govitrapong; Pichaya Jumnongprakhon; Apichart Suksamrarn; Jiraporn Tocharus
Journal:  Neurotox Res       Date:  2015-09-10       Impact factor: 3.911

2.  Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid.

Authors:  Anuradha Kalani; Pradip K Kamat; Srikanth Givvimani; Kasey Brown; Naira Metreveli; Suresh C Tyagi; Neetu Tyagi
Journal:  J Mol Neurosci       Date:  2014-02       Impact factor: 3.444

Review 3.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

Review 4.  Cerebral microhemorrhages: mechanisms, consequences, and prevention.

Authors:  Zoltan Ungvari; Stefano Tarantini; Angelia C Kirkpatrick; Anna Csiszar; Calin I Prodan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

5.  Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.

Authors:  Avisek Majumder; Mahavir Singh; Jyotirmaya Behera; Nicholas T Theilen; Akash K George; Neetu Tyagi; Naira Metreveli; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-15       Impact factor: 4.249

Review 6.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 7.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

Review 8.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

9.  Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.

Authors:  Anuradha Kalani; Pradip K Kamat; Anastasia Familtseva; Pankaj Chaturvedi; Nino Muradashvili; Nithya Narayanan; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

10.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.